Search
Your search found total of 463 results
How does NIH describe an Early Stage Investigator (ESI)?
What are the advantages of early stage investigator (ESI) status?
How does NIH describe an Early Stage Investigator (ESI)?
An ESI, or Early Stage Investigator, is a Program Director / Principal Investigator (PD/PI) who has completed…
Dr. Asifa Haider holds a Ph.D. in molecular pharmacology from New York Medical College, US, and is a licensed pharmacist from ETH-Zurich, Switzerland. She completed a postdoctoral fellowship at Rockefeller University, NY. She applied pharmacogenomics to evaluate the role of immune microenvironments…
After receiving her Ph.D. in developmental psychology from the University of Washington, Dr. Joann Wu Shortt dedicated over 15 years to prevention research at the Oregon Social Learning Center. As principal investigator and co-investigator on federally funded projects, her research focused on…
Using the ECR Application and Vetting System (EAVS) you can enroll or update your information. ECRs remain in the program until they no longer meet the criteria. For example, if you have been accepted into the program but receive an R01, you will be removed from our database of ECRs even if you…
NIH Will Consider Your Career Stage IfYou submit an R01 grant applicationYou are an Early Stage Investigator (ESI)A New Investigator is someone who has not previously received substantial independent funding from NIH. Having received an award for training (such as a fellowship or K award) does not…
Dr. Ivan Rebustini received his Ph.D. in biochemistry from the University of Sao Paulo and was a postdoctoral visiting fellow at the National Institute of Dental and Craniofacial Research (NIDCR), where he specialized in molecular, developmental, and regenerative biology. He joined Brigham and…
